Global NGS lab network delivering genetic tests across prenatal, oncology, and genomic profiling
Gene Solutions operates a distributed network of 14 NGS laboratories (three CAP-accredited hubs in Singapore, Vietnam, USA) processing genetic tests at clinical scale—over three million delivered to 5,000+ hospitals and clinics across six regions. The hiring profile is sales-heavy (14 of 31 active roles) with concurrent acceleration in market access and reimbursement work, indicating a shift from pure lab operations toward commercial scaling and payer navigation. Tech stack (Python, R, SQL, Nextflow, RAG) reflects a genomics-native engineering operation, though the hiring gap in pure engineering (2 roles) suggests reliance on existing pipelines rather than heavy platform development.
Notable leadership hires: Sales Director
Gene Solutions is an international biotechnology company founded in 2017, headquartered in Singapore, with laboratories and service coverage across Southeast Asia, Greater China, India, Turkey, Brazil, and the USA. The company provides a portfolio of genetic testing services built on Next-Generation Sequencing and proprietary AI algorithms, including cell-free DNA prenatal testing (NIPT), circulating tumor DNA cancer screening, genomic profiling, and treatment monitoring. The operational backbone spans three CAP-accredited central facilities plus 11 satellite or partner laboratories. Revenue generation flows through a network of 5,000+ hospitals and clinics that order tests; the company is actively navigating multi-region regulatory pathways, reimbursement models, and partnership structures to grow.
Cell-free DNA prenatal testing (NIPT), multi-cancer early detection (MCED), genomic and transcriptomic profiling, and ctDNA-based molecular residual disease (MRD) monitoring—all powered by Next-Generation Sequencing and proprietary AI algorithms.
Over three million tests delivered since founding in 2017, distributed to more than 5,000 hospitals and clinics across Southeast Asia, Greater China, India, Turkey, Brazil, and the USA.
Three CAP-accredited central facilities in Singapore, Vietnam, and the USA, plus 11 additional NGS laboratories across the global network.
Other companies in the same industry, closest in size